Inducible cysteine synthesis by CysK2 provides copper resistance in Mycobacterium tuberculosis
mBio · 2026
DOI: 10.1128/mbio.00888-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, 2026. Verfasst von Daisy X Ji und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, NYU Grossman School of Medicine, New York, New York, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Copper, Cysteine, Cysteine Synthase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Helen Hay Whitney Foundation.
Abstract (Originalsprache)
Copper is an essential nutrient that at high levels is toxic to life. Mammalian hosts can accumulate copper in phagolysosomes to restrict a variety of pathogens, including Mycobacterium tuberculosis . However, pathogens have evolved various mechanisms to counter copper stress. While several pathways that mitigate copper-derived toxicity have been described in Mycobacterium tuberculosis , the Mycobacterium tuberculosis lab strain H37Rv is significantly more sensitive to copper than other lab strains, including CDC1551 and Erdman. Here, we determine a cause of this sensitivity in H37Rv is due to a single amino acid substitution in CysK2 (Rv0848), which is encoded in the copper-inducible RicR regulon required for robust copper resistance and virulence. H37Rv CysK2 was previously reported as a S-sulfocysteine synthase. However, we found CysK2 is a cysteine synthase, the activity of which is required for resistance to copper. This study is the first to link de novo cysteine biosynthesis with copper resistance in Mycobacterium tuberculosis . IMPORTANCE Copper is a proposed component of the host immune response against Mycobacterium tuberculosis ; thus, an understanding of how this pathogen mitigates copper stress may yield new targets for therapeutics. Cysteine synthesis is implicated in copper responses in other bacterial species, but had not been shown in mycobacterial copper resistance. This study demonstrates for the first time that the Mycobacterium tuberculosis cysteine synthase CysK2 and, by extension, cysteine biosynthesis, can promote copper resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, NYU Grossman School of Medicine, New York, New York, USA.
- Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
ORCID-Profile: Daisy X Ji, K Heran Darwin
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Helen Hay Whitney Foundation
Zitieren
APA
Ji, D. X., Silvaggi, N. R., Benko, A., & Darwin, K. H. (2026). Inducible cysteine synthesis by CysK2 provides copper resistance in Mycobacterium tuberculosis. mBio. https://doi.org/10.1128/mbio.00888-26
Vancouver
Ji DX, Silvaggi NR, Benko A, Darwin KH. Inducible cysteine synthesis by CysK2 provides copper resistance in Mycobacterium tuberculosis. mBio. 2026. doi:10.1128/mbio.00888-26
BibTeX
@article{Ji2026,
author = {Ji, Daisy X and Silvaggi, Nicholas R and Benko, Anna and Darwin, K Heran},
title = {Inducible cysteine synthesis by CysK2 provides copper resistance in Mycobacterium tuberculosis},
journal = {mBio},
year = {2026},
doi = {10.1128/mbio.00888-26}
}
EUVIMED